Financhill
Back

Structure Therapeutics Quote, Financials, Valuation and Earnings

Structure Therapeutics Price Quote

$39.63
+0.64 (+1.64%)
(Updated: October 17, 2024 at 6:55 PM ET)

Structure Therapeutics Key Stats

Sell
36
Structure Therapeutics (GPCR) is a Sell

Day range:
$36.10 - $39.59
52-week range:
$26.61 - $75.02
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.46%

Volume:
759.9K
Avg. volume:
763.5K
1-year change:
-40.97%
Market cap:
$2.3B
Revenue:
$0
EPS:
$-2.22

How Much Does Structure Therapeutics Make?

Data Unavailable

Is Structure Therapeutics Growing As A Company?

Data Unavailable

Structure Therapeutics Stock Price Performance

What Is Structure Therapeutics 52-Week High & Low?

Structure Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Structure Therapeutics?

Is Structure Therapeutics Cash Flow Positive?

  • What Is GPCR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$102.8M
  • What Is Structure Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $797.5M
  • What Is Structure Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$353.7M

Structure Therapeutics Return On Invested Capital

Data Unavailable

Structure Therapeutics Earnings Date & Stock Price

Structure Therapeutics Competitors

Structure Therapeutics Dividend Yield

Structure Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 20%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 85.82
Upside from Last Price: 120.1%

Major Shareholders

  • How many GPCR shares are owned by institutional investors?
    122.2M GPCR shares are owned by institutional investors
  • How many GPCR shares are owned by insiders?
    2.2M GPCR shares are owned by insiders